Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADAMS S. S., CLIFFE E. E., LESSEL B., NICHOLSON J. S. SOME BIOLOGICAL PROPERTIES OF 'IBUFENAC', A NEW ANTI-RHEUMATIC DRUG. Nature. 1963 Oct 19;200:271–272. doi: 10.1038/200271b0. [DOI] [PubMed] [Google Scholar]
- CHALMERS T. M. CLINICAL TRIALS OF A NEW DRUG, IBUFENAC, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRELIMINARY REPORT. Ann Rheum Dis. 1963 Sep;22:358–362. doi: 10.1136/ard.22.5.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DRIVSHOLM A., MADSEN S. The influence of treatment with sodium salicylate on the serum glutamic oxalacetic transaminase activity. Scand J Clin Lab Invest. 1961;13:442–446. [PubMed] [Google Scholar]
- HAJNAL J., SHARP J., POPERT A. J. A method for testing analgesics in rheumatoid arthritis using a sequential procedure. Ann Rheum Dis. 1959 Sep;18:189–206. doi: 10.1136/ard.18.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TUDHOPE G. R. FAECAL BLOOD LOSS DURING TREATMENT WITH IBUFENAC, A NEW ANALGESIC DRUG. Ann Rheum Dis. 1964 Jan;23:30–32. doi: 10.1136/ard.23.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]